W. Pinover

发表

Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age

J. D. Chapman, A. Hanlon, E. Horwitz, 2000, Cancer.

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

T E Schultheiss, G E Hanks, B Movsas, 1998, International journal of radiation oncology, biology, physics.

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer.

A. Hanlon, G. Hanks, W. Pinover, 1999, Urology.

Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement.

A. Hanlon, E. Horwitz, R. Mitra, 2003, International journal of radiation oncology, biology, physics.

The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy.

A. Hanlon, E. Horwitz, G. Hanks, 1998, International journal of radiation oncology, biology, physics.

A rare case of primary pulmonary angiosarcoma

W. Pinover, Joel Alcid, 2017 .

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

Anne E. Calvaresi, P. Carroll, A. M. López, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

E. Horwitz, R. Uzzo, A. Pollack, 2003, Urology.

Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study.

A. Hanlon, E. Horwitz, B. Movsas, 2000 .

107 Increasing levels of hypoxia in human prostate carcinoma correlate significantly with increasing clinical stage and age: An Eppendorf p02 study

A. Hanlon, E. Horwitz, B. Movsas, 1999 .

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas

B. Eisenberg, H. Cooper, E. Ross, 2001, Journal of Gastrointestinal Surgery.

RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate

S. Rosenthal, G. Hanks, V. Venkatesan, 2000 .

Group B streptococcal meningitis in a pregnant woman before the onset of labor.

W. Pinover, T. I. Braun, P. Sih, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A comparison of Streptococcus pyogenes (group A streptococcal) bacteremia at an urban and a suburban hospital. The importance of intravenous drug use.

J. Kostman, V. Navarro, W. Pinover, 1993, Archives of internal medicine.

Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?

A. Hanlon, E. Horwitz, G. Hanks, 1999, Radiation oncology investigations.

The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer.

A. Hanlon, E. Horwitz, G. Hanks, 1999, International journal of radiation oncology, biology, physics.

Defining the optimal radiation dose with three‐dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques

A. Hanlon, E. Horwitz, G. Hanks, 2001, Cancer.

Hypoxia in Human Prostate Carcinoma

A. Hanlon, E. Horwitz, B. Movsas, 2001 .

Rectal Hodgkin's Disease in Acquired Immune Deficiency Syndrome

J. Cohn, W. Pinover, W. Tester, 1993, Journal of clinical gastroenterology.

115 Dose escalation with 3-D CRT in prostate cancer: Five year dose responses and optimal treatment

A. Hanlon, T. Schultheiss, B. Movsas, 1997 .

A relationship of local prostate dose and subsequent metastasis with 3D CRT in prostate cancer

A. Hanlon, E. Horwitz, T. Schultheiss, 1998 .

Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP).

I. Kaplan, D. Beyer, H. Sandler, 2016 .

Pancreatic cancer

Steven J. Cohen, N. Meropol, J. C. Watson, 2000, Current treatment options in oncology.

Hypoxic regions exist in human prostate carcinoma.

A. Hanlon, E. Horwitz, B. Movsas, 1999, Urology.

Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.

C. Willett, W. Pinover, A. Konski, 2008, International journal of radiation oncology, biology, physics.

Patterns and fate of PSA bouncing following 3D-CRT.

A. Hanlon, E. Horwitz, G. Hanks, 2001, International journal of radiation oncology, biology, physics.

Is there an increased risk of second primaries following prostate irradiation?

G E Hanks, B Movsas, A. Hanlon, 1998, International journal of radiation oncology, biology, physics.

Trimodality Therapy for Advanced Gallbladder Cancer

B. Eisenberg, E. Ross, A. Sasson, 2001, The American surgeon.

Regarding Vicini et al., IJROBP 1999,45:553-561.

A. Hanlon, E. Horwitz, G. Hanks, 2000, International Journal of Radiation Oncology, Biology, Physics.

Dose selection for prostate cancer patients based on dose comparison and dose response studies.

A. Hanlon, E. Horwitz, T. Schultheiss, 2000, International journal of radiation oncology, biology, physics.

Validation of a treatment policy for patients with prostate specific antigen failure after three‐dimensional conformal prostate radiation therapy

A. Hanlon, E. Horwitz, R. Uzzo, 2003, Cancer.

136 Dose escalation without split-course chemoradiation for anal cancer: Results of a phase II RTOG study

T. Pajak, W. Pinover, R. Myerson, 1997 .

Prostate Cancer Risk Assessment Program

M. Diefenbach, P. Engstrom, G. Hanks, 1999 .

Prostate cancer risk assessment program. A model for the early detection of prostate cancer.

M. Diefenbach, P. Engstrom, G. Hanks, 1999, Oncology.

Psychoeducational group intervention for wives of men with prostate cancer

E. Horwitz, S. Manne, J. Babb, 2004, Psycho-oncology.

Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer.

A. Hanlon, G. Hanks, W. Pinover, 2001, Urology.

A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer.

T E Schultheiss, G E Hanks, I Das, 1999, International journal of radiation oncology, biology, physics.

Conformai external beam treatment of prostate cancer

A. Hanlon, T. Schultheiss, B. Movsas, 1997 .

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.

I. Kaplan, D. Beyer, H. Sandler, 2018, International journal of radiation oncology, biology, physics.

Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy.

A. Hanlon, E. Horwitz, W. Pinover, 2001, International journal of radiation oncology, biology, physics.

Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants.

A. Hanlon, E. Horwitz, R. Uzzo, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypoxia in Human Prostate Carcinoma: An Eppendorf Po2 Study

A. Hanlon, E. Horwitz, B. Movsas, 2001, American journal of clinical oncology.

Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy.

T E Schultheiss, G E Hanks, A. Hanlon, 1999, The cancer journal from Scientific American.

Radiation therapy as treatment for stage T1c prostate cancers

A. Hanlon, T. Schultheiss, G. Hanks, 2005, World Journal of Urology.

Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control.

Alexandra L Hanlon, Joseph M Kaminski, A. Hanlon, 2002, International journal of radiation oncology, biology, physics.

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

I. Kaplan, D. Beyer, H. Sandler, 2016 .

Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer.

A. Hanlon, E. Horwitz, G. Hanks, 2000, International journal of radiation oncology, biology, physics.

Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?

A. Hanlon, G. Hanks, T. Al-Saleem, 1999, Radiation oncology investigations.

Conformal external beam treatment of prostate cancer.

A. Hanlon, B. Movsas, M. Hunt, 1997, Urology.

Conformal external beam treatment of prostate cancer. Commentary

A. Hanlon, T. Pisansky, T. Schultheiss, 1997 .

Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method.

E. Horwitz, G. Hanks, R. Price, 2002, International journal of radiation oncology, biology, physics.

To move or not to move: measurements of prostate motion by urethrography using MRI.

E. Horwitz, B. Movsas, R. Mitra, 2001, International journal of radiation oncology, biology, physics.

Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).

L. Gaspar, L. Gunderson, W. Kocha, 2001, Cancer journal.

Prostate carcinoma patients upstaged by imaging and treated with irradiation: An outcome‐based analysis

G. Hanks, W. Lee, A. Hanlon, 1996, Cancer.

Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy

A. Hanlon, G. Hanks, W. Pinover, 1999, Cancer.

Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three‐dimensional conformal external beam radiation therapy

A. Hanlon, E. Horwitz, G. Hanks, 2000, Cancer.

The ASTRO consensus definition of bNED failure is an inappropriate endpoint for prostate cancer patients receiving conformal radiation therapy and androgen deprivation (CRT+AD)

A. Hanlon, E. Horwitz, G. Hanks, 1998 .